'Roche could've earned over 100 times what it cost for...

Dununu.com Dununu

Sponsorluk

'Roche could've earned over 100 times what it cost for rare disease drug'

RSS Feed National

Posted

135

Public health activists estimate Roche earned significantly more from risdiplam, a spinal muscular atrophy drug, than its development costs. Roche disputes this, citing expenses from unsuccessful projects and ongoing research. While the drug remains unaffordable for many in India, Roche offers access programs and free treatment to some patients.

Read Full Article

Please log in to like, share and comment!

Ahaan-Aneet's 'Saiyaara' makes impressive Rs 20 crore debut

Ahaan Panday and Aneet Padda's film 'Saiyaara' has made a strong debut. The movie earned Rs 20...

By 0 0

Heavy rain likely in parts of Koshi and Gandaki provinces

KATHMANDU: Monsoon winds continue to affect the country, with the monsoon’s low-pressure...

By 0 14

‘Little group fading fast’: Donald Trump mocks Brics; reiterates 10% tariff threat to protect US dollar dominance

Donald Trump dismissed the Brics group as fading and threatened tariffs on nations aligning with...

By 0 23

Dr. Om Murti Anil’s Untold Fight against Heart Disease

While most medical recognition focuses on new treatments, Dr. Om Murti Anil, a Nepali...

By 0 25

India cries foul as EU curbs on Russia hit Gujarat refinery

By 0 29